These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 30964176)
1. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells. Wang JJ; Yu JP Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176 [TBL] [Abstract][Full Text] [Related]
2. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells. Zhang JY; Li YN; Mu X; Pan ZL; Liu WB Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899 [TBL] [Abstract][Full Text] [Related]
3. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance. Chen LZ; Ding Z; Zhang Y; He ST; Wang XH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147 [TBL] [Abstract][Full Text] [Related]
4. miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1. Liu Y; Zhang M Cancer Biother Radiopharm; 2019 Aug; 34(6):398-404. PubMed ID: 30939040 [No Abstract] [Full Text] [Related]
5. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway. Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482 [TBL] [Abstract][Full Text] [Related]
6. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin. Han GY; Cui JH; Liang S; Li HL Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312 [TBL] [Abstract][Full Text] [Related]
7. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance. Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. He Q; Zhou X; Li S; Jin Y; Chen Z; Chen D; Cai Y; Liu Z; Zhao T; Wang A Biochim Biophys Acta; 2013 Nov; 1830(11):5258-66. PubMed ID: 23911747 [TBL] [Abstract][Full Text] [Related]
9. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1. Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183 [TBL] [Abstract][Full Text] [Related]
10. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells. Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472 [No Abstract] [Full Text] [Related]
11. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. Bai H; Cao Z; Deng C; Zhou L; Wang C J Cancer Res Clin Oncol; 2012 Apr; 138(4):595-602. PubMed ID: 22209977 [TBL] [Abstract][Full Text] [Related]
12. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway. Wang DW; Wang YQ; Shu HS Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480 [TBL] [Abstract][Full Text] [Related]
13. [Effect and Mechanism of Atorvastatin on Reversing Drug Resistance in Leukemia by Regulating Glycolysis through PTEN/mTOR Pathway]. Liu M; Zhou P Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):38-44. PubMed ID: 36765474 [TBL] [Abstract][Full Text] [Related]
14. [MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM]. Hua JY; Feng Y; Pang Y; Zhou XH; Xu B; Yan MX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):347-51. PubMed ID: 27150990 [TBL] [Abstract][Full Text] [Related]
15. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway. Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558 [TBL] [Abstract][Full Text] [Related]
17. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia. Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL. Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884 [TBL] [Abstract][Full Text] [Related]
19. [MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid Leukemia]. Gan DY; Wu J; Zhou M; Chen W; Jiang W Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):39-44. PubMed ID: 38387897 [TBL] [Abstract][Full Text] [Related]
20. Bta-miR-34b inhibits proliferation and promotes apoptosis via the MEK/ERK pathway by targeting MAP2K1 in bovine primary Sertoli cells. Zhang L; Ma T; Tao Q; Tan W; Chen H; Liu W; Lin P; Zhou D; Wang A; Jin Y; Tang K J Anim Sci; 2020 Oct; 98(10):. PubMed ID: 32954430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]